MedTrace Logo

REGistry of Long-term AnTithrombotic TherApy-2

NCT04347187 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2026-05-01

No results posted yet for this study

Summary

To assess the rates of ischemic and hemorrhagic complications of long-term antithrombotic therapy in patients with atrial fibrillation

Conditions

Interventions

DRUG

Anticoagulants

oral anticoagulants, dual or triple antithrombotic theraphy

Sponsors & Collaborators

  • National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

    lead OTHER_GOV

Principal Investigators

  • Elizaveta Panchenko, PhD · National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-15
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04347187 on ClinicalTrials.gov